Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.

National University of Malaysia197 enrolled

Overview

This is a prospective clinical study aiming to investigate on the transplacental antibody transmission post Covid-19 infection during pregnancy.

Covid -19 infection has been a significant public health burden as it shifted the paradigm of infectious diseases aiming to control the spread and enhance public immune protection. The introduction of Covid -19 vaccination in December 2020 aimed to combat the infection, thus tremendously helping to flatten the disease worldwide. Channeling the vaccine for the obstetrics field is one of the hallmark strategies to reduce maternal morbidity and mortality. The efficacy of vaccination for the pregnant lady has been established. However, fetus protection via transmission of the antibody during pregnancy is still uncertain. Therefore, this study aims to consolidate further evidence of transplacental antibody post-maternal vaccination aiming for fetal protection following delivery.

Study Type

OBSERVATIONAL

Enrollment

197

Conditions

Antibody Vaccine Maternal Cord

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * term pregnancies at 37 weeks or more * vaccinated 2 doses * in labour Exclusion Criteria: * unvaccinated * preterm labour less than 37 weeks * multiple pregnancies

Locations (1)

UKM Medical Center

Kuala Lumpur, W.Persekutuan, Malaysia

Outcomes

Primary Outcomes

Maternal to Neonatal Transmission Antibody Covid-19 Study - The TRAB CoV-19

Quantification of Covid-19 antibody levels in maternal and cord blood samples

Time frame: 30 minutes after delivery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.